Lee, Rachel M.
Vitolo, Michele I.
Losert, Wolfgang
Martin, Stuart S.
Funding for this research was provided by:
National Institutes of Health (T32-CA154274, R01-CA154624)
Air Force Office of Scientific Research (FA9550-16-1-0052, FA9550-16-1-0052)
American Cancer Society (RSG-18-028-01-CSM)
Biomedical Laboratory Research and Development, VA Office of Research and Development (I01-BX002746)
Article History
Received: 1 October 2020
Accepted: 10 March 2021
First Online: 13 May 2021
Competing interests
: The PTEN<sup>−/−</sup> cells are licensed by Horizon Discovery Ltd. (Cambridge, UK). Dr. Vitolo receives compensation from the sale of these cells. The remaining authors declare no conflict of interest.